New drug duo tested to halt aggressive sarcoma
NCT ID NCT04200443
Summary
This study is testing whether combining two drugs, cabozantinib and temozolomide, can better control advanced soft tissue sarcomas that cannot be removed by surgery or have spread. The trial aims to see if this combination can stop the cancer from growing for longer and improve survival. It is for adults with specific types of advanced sarcoma who have had up to five prior treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III UTERINE CORPUS LEIOMYOSARCOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.